CYP11B1 Gene Adrenal Hyperplasia due to Steroid 11-Beta-Hydroxylase Deficiency Genetic Test in UAE | DNA Labs UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).

Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.

Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by Consultant Medical Genetics.

Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This test sequences the CYP11B1 gene to diagnose congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency, guiding precise hormone replacement therapy. The analysis employs next-generation sequencing (NGS) to detect pathogenic variants across the full coding region and splice sites, enabling definitive molecular diagnosis, carrier detection, and informed family planning.

Feature	Our Test (NGS)	Closest Alternative (Hormonal Assay)
Precision	>99.9% variant detection; full gene coverage including intronic boundaries	Indirect via 17-OHP levels; variable sensitivity with frequent false positives
Methodology	NGS (Next Generation Sequencing) with Sanger confirmation	Immunoassay / LC-MS/MS
Turnaround Time	3 – 4 Weeks	Same day to 1 week
Clinical Utility	Definitive molecular diagnosis; carrier detection; family planning guidance	Screening only; cannot differentiate CAH subtypes
Price	2,800 AED	200 – 500 AED

Physician Insight & Safety Protocols

“Interpreting CYP11B1 variants requires careful correlation with biochemical profiles and clinical presentation. This NGS panel captures single nucleotide variants, small indels, and copy number changes across the entire gene, enabling precise subtyping of 11-beta-hydroxylase deficiency. A negative result does not exclude other enzymatic defects in the corticosteroid biosynthetic pathway; comprehensive metabolic workup remains essential.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Medication Safety Advisory

Do not alter or discontinue prescribed glucocorticoid or mineralocorticoid therapy without consulting your managing physician. Abrupt cessation can precipitate life-threatening adrenal crisis.

Exclusion Criteria for Home Collection

Active febrile illness (>38.5°C) or systemic infection
Severe bleeding disorder (e.g., hemophilia) without prior medical clearance
Inability to provide informed consent

Emergency Red Flags

If you experience sudden severe headache, vomiting, confusion, or loss of consciousness (signs of adrenal crisis), proceed to the nearest emergency department immediately.

Patient FAQ & Clinical Guidance

1. What is the CYP11B1 genetic test used for?

This test diagnoses congenital adrenal hyperplasia caused by 11-beta-hydroxylase deficiency, a disorder impairing cortisol and aldosterone production while driving excess androgen synthesis. It confirms the molecular basis of the condition, differentiates it from other CAH subtypes such as 21-hydroxylase deficiency, and informs lifelong hormone replacement strategies.

2. How is the sample collected and when will I receive results?

A simple blood draw from a peripheral vein or a dried blood spot on an FTA card is collected via VIP mobile phlebotomy at your home. Results are typically available within 3 to 4 weeks. A pre-test genetic counselling session is arranged to document family history and construct a pedigree chart.

3. Is the test covered by insurance in the UAE?

We offer direct insurance billing verification. Contact us on WhatsApp at +971 54 548 8731 to confirm coverage before booking. Many UAE insurers cover genetic testing for adrenal hyperplasia when deemed medically necessary; pre-authorization is strongly recommended.

4. What do the results mean for my treatment plan?

A positive result confirms the specific enzyme deficiency, allowing your endocrinologist to tailor glucocorticoid and mineralocorticoid replacement therapy precisely. Carrier results inform family screening and reproductive planning. All results are reviewed in a post-test telephonic consultation with our genetics specialist.

UAE Regulatory & Data Privacy Adherence

Data Protection Framework: All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory processing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name	CYP11B1 Gene Adrenal Hyperplasia due to Steroid 11-Beta-Hydroxylase Deficiency Genetic Test
Price (AED)	2,800 AED
Turnaround Time	3 – 4 Weeks
Sample Type / Matrix	Peripheral Whole Blood or FTA Card (Dried Blood Spot)
Methodology Used	Next Generation Sequencing (NGS) with Sanger Confirmation
ICD-10-CM Code	E25.0, E25.8, E25.9
LOINC Code	90234-2
DHA Facility License & Laboratory Address	License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians